麗珠醫藥(01513.HK)與健康元終止合夥協議及以現金投資方式成立合資公司
格隆匯12月12日丨麗珠醫藥(01513.HK)公吿,經慎重考慮和討論,公司與健康元決定將共同投資形式由合夥企業變更為合資公司。於2022年12月12日,經董事會批准,公司與健康元訂立合作框架協議,據此,公司與健康元同意(i)終止合夥協議;及(ii)以現金投資的方式成立合資公司,其中公司將出資人民幣6億元及健康元將出資人民幣4億元。因此,公司及健康元將分別直接擁有合資公司的60%及40%權益。
董事認為,公司與健康元共同投資成立合資公司,並以合資公司為主體尋求對公司所在產業內項目進行戰略投資,符合公司的長遠發展戰略,有利於強化公司的行業優勢地位,擴大產品管線佈局,提升綜合競爭力,對公司未來發展具有積極意義。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.